Arkolith/Insider Trading/TNXP/Form 4

Lederman Seth

Chief Executive Officer, DirectorTonix Pharmaceuticals Holding Corp. (TNXP) · full profile →Form 4 · filed May 15, 2025
Net Buying
Open-Market Buys
$86K
Open-Market Sells
$0
Net Open-Market Flow
$86K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2025Buy(P)4K$21.55$86K4K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999371-25-006261) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML